CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Antibiotic susceptibility patterns of community and hospital acquired urinary isolates of Escherichia coli

Author: 
Fouzia Haider, Bashayer Matar Quhimea Al-huthali, Reem Ahmed Khalaf Alghuraybi, Ghadeer Jassim Mohammad Zahiri and Wejdan Mustafa bakur Barnawi
Subject Area: 
Life Sciences
Abstract: 

Background: Escherichia coli accounts for majority of community and hospital acquired urinary tract infections in many parts of the world. It has developed resistance against antimicrobial agents and it is necessary to have up to date knowledge of drug resistance pattern for treatment of UTIs caused by this organism. Objective: To determine and compare antimicrobial susceptibility patterns of urinary. E.coli isolated from patients with community and hospital acquired UTIs in Makkah Saudi Arabia. Materials and Methods: This prospective descriptive study was performed for a period of three months. A total of 92 Escherichia coli isolated from urine samples were collected from four hospitals of Makkah. The clinical and demographic information of the patients was collected using a predesigned questionnaire. Isolates were confirmed by using bacteriological methods and API 20E kits. All E.coli strains were subjected to in vitro susceptibility testing using Kirby Bauer disk diffusion method as described in CLSI guidelines. Results: The study was performed in patients of all age groups and both the genders. Majority of the patients were in age group1-10 years and 21-30 years in community acquired infections and1-10 years followed by 21-30 years and 70-80 years in hospital acquired infections. A predominance of female patients (73%) compared to male patients (27%) was seen. Majority of the urinary tract infections were community acquired (55%) compared to hospital acquired (45).Over all antibiotic resistance data of 92 isolates showed low to high resistance to all drugs tested (2.17-100%). The highest resistance was exhibited by ampicillin (100%) followed by cephalothin (65.2%) and trimethoprim/sulphamethoxazole (64.1%). The rates of drug resistance for other antibiotics were: cefuroxime 36.9%, norfloxan29.3%, levofloxacin 28.2%, ceftazidime 18.4 %, amoxicillin/clavulanic acid 14.1%and cefoxitin 11.9%. Among all antibiotics tested imipenem showed lowest resistance (2.17%). In summary, highest resistance was seen against ampicillin followed by cephalothin and trimethoprim/sulphamethoxazole and least resistance was shown against imepenim. Moreover, higher resistance was seen in hospital acquired infections compared tocommunity acquired infections. Very high level of MDR was also seen (60%) among isolates from all the hospitals. Conclusion: This study showed low to high drug resistance of E.coli isolates from various hospitals of Makkah. Alarming rates of MDR among community acquired as well as nosocomial isolates call for continuous periodic monitoring in Makkah region to know the developing resistance pattern which, will help in deciding the most adequate therapy for E.coli urinary tract infections.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran